» Authors » Eric C Dietze

Eric C Dietze

Explore the profile of Eric C Dietze including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 507
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vidal C, Alva-Ornelas J, Chen N, Senapati P, Tomsic J, Robles V, et al.
Cancers (Basel) . 2024 Aug; 16(15). PMID: 39123463
Background: Epigenetic changes link medical, social, and environmental factors with cardiovascular and kidney disease and, more recently, with cancer. The mechanistic link between metabolic health and epigenetic changes is only...
2.
Sistrunk C, Tolbert N, Sanchez-Pino M, Erhunmwunsee L, Wright N, Jones V, et al.
Front Cardiovasc Med . 2022 May; 9:756734. PMID: 35509276
Racist and discriminatory federal, state, and local housing policies significantly contribute to disparities in cardiovascular disease incidence and mortality for individuals that self-identify as Black or African American. Here we...
3.
Skaar D, Dietze E, Alva-Ornelas J, Ann D, Schones D, Hyslop T, et al.
Cancers (Basel) . 2021 Dec; 13(23). PMID: 34885139
Genomic imprinting is an inherited form of parent-of-origin specific epigenetic gene regulation that is dysregulated by poor prenatal nutrition and environmental toxins. encodes for TASK3, a pH-regulated potassium channel membrane...
4.
Tossas-Milligan K, Shalabi S, Jones V, Keely P, Conklin M, Eliceiri K, et al.
Curr Breast Cancer Rep . 2020 Dec; 11(3):100-110. PMID: 33312342
Purpose: Here we aim to review the association between mammographic density, collagen structure and breast cancer risk. Findings: While mammographic density is a strong predictor of breast cancer risk in...
5.
Jones V, Dietze E, Jovanovic-Talisman T, McCune J, Seewaldt V
Front Public Health . 2020 Nov; 8:509714. PMID: 33194937
Currently, tamoxifen is the only drug approved for reduction of breast cancer risk in premenopausal women. The significant cardiovascular side effects of tamoxifen, coupled with lack of a survival benefit,...
6.
Frankhauser D, Jovanovic-Talisman T, Lai L, Yee L, Wang L, Mahabal A, et al.
WIREs Mech Dis . 2020 Oct; 13(2):e1506. PMID: 33001587
Over 90% of breast cancer is cured; yet there remain highly aggressive breast cancers that develop rapidly and are extremely difficult to treat, much less prevent. Breast cancers that rapidly...
7.
Yee L, Mortimer J, Natarajan R, Dietze E, Seewaldt V
Front Endocrinol (Lausanne) . 2020 Mar; 11:58. PMID: 32153503
Studies investigating the potential link between adult pre-menopausal obesity [as measured by body mass index (BMI)] and triple-negative breast cancer have been inconsistent. Recent studies show that BMI is not...
8.
Natarajan R, Aljaber D, Au D, Thai C, Sanchez A, Nunez A, et al.
Int J Environ Res Public Health . 2020 Jan; 17(2). PMID: 31941024
During puberty, a woman's breasts are vulnerable to environmental damage ("window of vulnerability"). Early exposure to environmental carcinogens, endocrine disruptors, and unhealthy foods (refined sugar, processed fats, food additives) are...
9.
Dietze E, Chavez T, Seewaldt V
Am J Pathol . 2017 Nov; 188(2):280-290. PMID: 29128565
Once considered a problem of Western nations, obesity (body mass index ≥30 kg/m) has rapidly increased since the 1970s to become a major threat to world health. Since 1970, the...
10.
Dietze E, Sistrunk C, Miranda-Carboni G, ORegan R, Seewaldt V
Nat Rev Cancer . 2015 Feb; 15(4):248-54. PMID: 25673085
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that disproportionately affects BRCA1 mutation carriers and young women of African origin. There is evidence that African-American women with TNBC...